Fundraising Fox
/Companies
Sign in

RegCell

7 known investors

Find your way into RegCell

Sign up to see every warm intro you have to RegCell

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the RegCell team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

RegCell Biosciences is a biotechnology company developing regenerative cell therapies, leveraging expertise in cell and gene therapy, manufacturing, and immunology to advance therapeutic treatments.

BiotechDeep TechMedical Devices

Founders & leadership

MM
Michael McCullar, PhDChief Executive Officer
JA
James AhlersChief Financial Officer
MG
Marty Giedlin, PhDChief Technology Officer
TH
Tony HurleyChief Technical Operations Officer
SKSteve Kanner, PhD
Steve Kanner, PhDChief Scientific Officer

Investors · 7

Global Brainlisted by Global BrainTokyo · $100K

How we know: Global Brain's portfolio page · Not right? Tell us

Kyoto University Innovation Capitallisted by Kyoto University Innovation CapitalKyoto

How we know: Kyoto University Innovation Capital's portfolio page · packgene.com · Not right? Tell us

UTEClisted by UTECTokyo

How we know: packgene.com · the VCSheet dataset · Not right? Tell us

Mitsubishi UFJ CapitalreportedTokyo

How we know: packgene.com · Not right? Tell us

OSAKA University Venture CapitalreportedOsaka

How we know: packgene.com · Not right? Tell us

Also in the syndicate · 1

Celadon Partners

Funding

SEC filings, press & company announcements

$45M disclosed across 1 of 2 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 3

Regeneron NASDAQ: REGN www.regeneron.comRegeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease. The company focuses on research and development driven by human biology, with a clinical trial pipeline addressing conditions like generalized myasthenia gravis.
Read on Scientific AmericanScientific American is a media organization that publishes research and ideas across science, health, technology and society through multiple formats including print, web, video, and podcasts. Founded in 1845, it reaches over 20 million people monthly and maintains editorial independence while providing trustworthy science communication and commentary.
LyellLyell develops CAR T-cell therapies for cancer patients by leveraging deep expertise in T-cell biology and oncology. The company operates an integrated pipeline spanning discovery through manufacturing and clinical trials, with its own manufacturing facility in Washington.

Companies working in the same space as RegCell.

In the news

Japanese-Founded Regulatory T-cell Reprogramming Company RegCell Secures $45.8M in Funding and Completes U.S. Headquarters Transition - RegCellregcellbio.com · Mar 2025RegCell Raises $45.8M in Fundingfinsmes.com · Mar 2025

Frequently asked questions

What does RegCell do?
RegCell Biosciences is a biotechnology company developing regenerative cell therapies, leveraging expertise in cell and gene therapy, manufacturing, and immunology to advance therapeutic treatments.
Who are RegCell's investors?
RegCell's investors include Fast Track Initiative, Global Brain, Kyoto University Innovation Capital, UTEC, Mitsubishi UFJ Capital, OSAKA University Venture Capital.
How much funding has RegCell raised?
RegCell has disclosed $45M raised across 1 of its 2 known rounds.